Hydroquinone 4% (hydroquinone) NDC 75834-137

NDC codes

FDA NDC Directory

Product NDC (as listed)75834-137Labeler and product segments. Claims need a package NDC.

Product NDC at billing width75834-0137Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
75834-137-01	75834013701	1 TUBE in 1 CARTON (75834-137-01) / 28.4 g in 1 TUBEMarketed from Aug 17, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydroquinone 4%
Generic name (nonproprietary): hydroquinone
Active ingredients: Hydroquinone — 40 mg/g
Dosage form: Cream
Route: Topical
Labeler: Nivagen Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Aug 17, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Depigmenting Activity (Physiologic effect)Melanin Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 75834-137_8342b27f-c6a6-44cd-bdbf-54671ef07e0aSPL ID 8342b27f-c6a6-44cd-bdbf-54671ef07e0aSPL set ID 7844c308-e0a2-42e7-bd28-f68a59ebca83RxCUI 197795UNII XV74C1N1AE
Pharmacologic class: Melanin Synthesis Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475834013701 followed by a unit qualifier and the quantity

Package 75834-0137-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 20, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE Hydroquinone USP, 4% Skin Bleaching Cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)